Possibilities of using hemostasis markers and parameters of hemostatic potential for predicting thrombotic complications in patients with CKD stage VD


Keywords: hemostasis, hemodialysis, fibrinolytic coefficient, thrombotic risk.

Abstract

Annotation. Violations in the hemostatic system of patients with chronic kidney disease (CKD) of the VD stage treated with program hemodialysis are associated with a high thrombotic risk. Comprehensive studies of the possible causes and predictors of thrombophilia can improve the therapeutic and prophylactic measures to combat thrombotic complications. The search for available methods for predicting these complications is very relevant. The goal is to develop a method for predicting the development of thrombotic complications in this category of patients, which would allow identifying the degree of hemostasis disorders. We examined 88 patients with CKD VD, treated with program hemodialysis, who determined the fibrinolytic potential and the level of soluble fibrin and D-dimer by enzyme immunoassay. It is proposed to use the developed fibrinolytic coefficient (Fc) to predict thrombotic complications. It was found that the proposed method for assessing hemostasis using Fc makes it possible to objectively characterize the state of the coagulation link and can serve as an indicator of thrombotic risk.

References

1. Komisarenko, S. V., Luhovskoi, E. V., Kolesnikova, I. M., Spivak, M. Ya., Hryshchenko, P. H., Kostiuchenko, O. P., … Tereshchenko, M. I. (2012). Test systema imunofermentna dlia kilkisnoho vyznachennia rozchynnoho fibrynu v plazmi krovi liudyny [Test enzyme immunoassay for the quantitative determination of soluble fibrin in human blood plasma]. Patent № 69283, Ukraina, MPK A61K 39/44. Kyiv: Derzhavne patentne vidomstvo Ukrainy.

2. Komisarenko, S. V., Luhovskoi, E. V., Kolesnikova, I. M., Spivak, M. Ya., Hryshchenko, P. H., Hanova, L. O., … Tereshchenko, M. I. (2012). Test systema imunofermentna dlia kilkisnoho vyznachennia D-dymeru v plazmi krovi liudyny [The enzyme-linked immunosorbent assay for quantitative determination of D-dimer in human blood plasma]. Patent № 69284, Ukraina, MPK A61K 39/4. Kyiv: Derzhavne patentne vidomstvo Ukrainy.

3. Luhovskoi, E. V., Komisarenko, S. V., Platonova, T. M., Rublenko, A. M., Fishchenko, V. O., Kolesnikova, I. N., … Chernyshenko, T. M. (2013). Vyznachennia vmistu rozchynnoho fibrynu ta D-dymeru dlia prohnozuvannia trombotychnykh uskladnen za endoprotezuvannia kulshovoho suhloba [Determination of soluble fibrin and D-dimer content for prognosis of thrombotic complications of hip joint replacement]. Laboratorna diahnostyka – Laboratory Diagnostics, 2(54), 3–8. Vziato z http://nbuv.gov.ua/UJRN/labdiag_2013_2_2.

4. Rublenko, A. M., Urvant, L. P., Makohonenko, E. M., Platonova, T. M., Tsap, R. Yu., Chernyshenko, T. M., … Luhovskoi, E. V. (2011). Vplyv aktyvatora proteinu S na zahalnyi hemostatychnyi potentsial plazmy krovi za endoprotezuvannia tazostehnovoho suhloba [Influence of protein C activator on the total hemostatic potential of blood plasma for hip replacement]. Ukrainskyi biokhimichnyi zhurnal – Ukrainian Biochemical Journal, 5, 32–38. Vziato z http://nbuv.gov.ua/UJRN/BioChem_2011_83_5_7.

5. Goluza, E., Topalovic, M. G., Hudolin, T., Konosic, S., Kocman, I. B., & Peric, V. (2011). Disorders of hemostasis in chronic renal failure and renal transplantation. Acta Med. Croatica, 65(4), 3337–47. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22359906.

6. Rios, D. R., Fernandes, A. P., Cervalho, M. G., Figueiredo, R. C., Guimaraes, D. A., Reis, D. R., … Dusse, L. M. (2011). Hemodialisas vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation ABO blood groups. Clin. Chim. Acta, 412(5–6), 425–9. doi: 10.1016/j.cca.2010.11.002.

7. Stolic, R. V., Trajkovic, G. Z., Peric, V. M., Jovanovic, A. N., Markovic, S. R., … Subaric-Gorgieva, GDj. (2008). The influence of atherosclerosis and plasma D-dimer concentration in patients with a functioning arteriovenous fistula for maintenance hemodialisys. Int. Urol. Nephrol., 40(2), 503–8. doi: 10.1007/s11255-007-9321-8.
Published
2019-12-30
How to Cite
Storozhuk, O., Shevchuk, S., Seleznyova, I., Storozhuk, L., Dovgalyuk, T., & Storozhuk, B. (2019). Possibilities of using hemostasis markers and parameters of hemostatic potential for predicting thrombotic complications in patients with CKD stage VD. Reports of Vinnytsia National Medical University, 23(4), 677-680. https://doi.org/https://doi.org/10.31393/reports-vnmedical-2019-23(4)-20